Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 14-Aug-24 7:19 PM View:  | Morris Jeffrey Allen 10% Owner | Provectus Pharmaceuticals, ... (PVCT) | 12-Aug-24 | Conversion | 264,314 | $2.86 | $756,467.00 | 1% 22.5M to 22.76M | |
| 09-May-23 4:50 PM View: | Morris Jeffrey Allen 10% Owner | Provectus Pharmaceuticals, ... (PVCT) | 08-May-23 | Conversion | 188,757 | $2.86 | $540,223.00 | < 1% 22.31M to 22.5M | |
| 12-Nov-20 8:01 PM View: | Horowitz Bruce Chief Operating Officer Director | Provectus Pharmaceuticals, ... (PVCT) | 10-Nov-20 | Grant | 800,000 | -- | -- | 54% 1.48M to 2.28M | |
| 12-Nov-20 8:04 PM View: | Lacy John III Director | Provectus Pharmaceuticals, ... (PVCT) | 10-Nov-20 | Grant | 100,000 | -- | -- | 100% 100.45K to 200.45K | |
| 12-Nov-20 8:05 PM View: | Raines Heather CFO | Provectus Pharmaceuticals, ... (PVCT) | 10-Nov-20 | Grant | 50,000 | -- | -- | 4% 1.16M to 1.21M | |
| 27-Mar-19 9:53 AM View: | Raines Heather Chief Financial Officer | Provectus Pharmaceuticals, ... (PVCT) | 25-Mar-19 | Grant | 50,000 | -- | -- | 4% 1.11M to 1.16M | |
| 18-Dec-17 12:20 PM View: | Glass John R See Remarks | Provectus Pharmaceuticals, ... (PVCT) | 14-Dec-17 | Market Purchase | 200,000 | $0.05 | $10,791.60 | 100% 0 to 200.0K | (7%) |
| 31-Mar-16 7:34 PM View: | Wachter Eric Phd Chief Technology Officer Director | Provectus Pharmaceuticals, ... (PVCT) | 29-Mar-16 | Exercise (out-of-the-money) | 106,000 | $1.00 | $106,000.00 | 2% 6.54M to 6.65M | |
| 31-Mar-16 7:31 PM View: | Koe Jan Director | Provectus Pharmaceuticals, ... (PVCT) | 29-Mar-16 | Exercise (out-of-the-money) | 200,000 | $1.25 | $250,000.00 | 27% 736.3K to 936.3K | |
| 31-Mar-16 7:35 PM View: | Culpepper Peter R Interim CEO, CFO, COO | Provectus Pharmaceuticals, ... (PVCT) | 29-Mar-16 | Exercise (out-of-the-money) | 160,666 | $1.00 | $160,666.00 | 11% 1.44M to 1.6M | |
| 31-Mar-16 7:34 PM View: | Wachter Eric Phd Chief Technology Officer Director | Provectus Pharmaceuticals, ... (PVCT) | 29-Mar-16 | Exercise (out-of-the-money) | 200,947 | $1.00 | $200,947.00 | 3% 6.34M to 6.54M | |
| 31-Mar-16 7:35 PM View: | Culpepper Peter R Interim CEO, CFO, COO | Provectus Pharmaceuticals, ... (PVCT) | 29-Mar-16 | Exercise (out-of-the-money) Duplicate | 106,000 | $1.00 | $106,000.00 | 7% 1.6M to 1.71M | |
| 22-Dec-15 8:01 PM View: | Wachter Eric Phd Chief Technology Officer | Provectus Pharmaceuticals, ... (PVCT) | 21-Dec-15 | Option Exercise | 120,000 | $1.02 | $122,400.00 | 2% 6.22M to 6.34M | |
| 10-Dec-15 1:44 PM View: | Culpepper Peter R CFO & COO | Provectus Pharmaceuticals, ... (PVCT) | 09-Dec-15 | Option Exercise | 138,831 | $0.94 | $130,501.00 | 11% 1.3M to 1.44M | |
| 10-Dec-15 1:44 PM View: | Culpepper Peter R CFO & COO | Provectus Pharmaceuticals, ... (PVCT) | 09-Dec-15 | Option Exercise | 6,383 | $0.94 | $6,000.02 | < 1% 1.44M to 1.44M | |
| 26-Jan-15 1:05 PM View: | Wachter Eric Phd Chief Technology Officer | Provectus Pharmaceuticals, ... (PVCT) | 24-Jan-15 | Option Exercise | 185,000 | $1.02 | $188,700.00 | 3% 6.04M to 6.22M | |
| 07-Jan-15 3:28 PM View: | Scott Timothy Phd President Director | Provectus Pharmaceuticals, ... (PVCT) | 07-Jan-15 | Option Exercise | 76,764 | $0.64 | $49,129.00 | 4% 2.0M to 2.08M | |
| 07-Jan-15 3:29 PM View: | Culpepper Peter R CFO & COO | Provectus Pharmaceuticals, ... (PVCT) | 07-Jan-15 | Option Exercise | 63,120 | $0.84 | $52,999.30 | 5% 1.23M to 1.3M | (88%) |
| 30-Dec-14 4:27 PM View: | Scott Timothy Phd President Director | Provectus Pharmaceuticals, ... (PVCT) | 30-Dec-14 | Option Exercise | 126,361 | $0.64 | $80,871.00 | 7% 1.88M to 2.0M | |
| 31-Oct-14 9:45 PM View: | Scott Timothy Phd President Director | Provectus Pharmaceuticals, ... (PVCT) | 29-Oct-14 | Option Exercise | 96,875 | $0.64 | $62,000.00 | 5% 1.78M to 1.88M | |
| 01-Jul-14 10:22 AM View: | Culpepper Peter R CFO & COO | Provectus Pharmaceuticals, ... (PVCT) | 28-Jun-14 | Option Exercise | 100,000 | $1.25 | $125,000.00 | 9% 1.13M to 1.23M | |
| 20-May-14 6:07 AM View: | Scott Timothy Phd President | Provectus Pharmaceuticals, ... (PVCT) | 19-May-14 | Option Exercise | 25,000 | $0.95 | $23,750.00 | (1%) 1.81M to 1.78M | |
| 24-Mar-14 5:17 PM View: | Wachter Eric Phd Chief Technology Officer | Provectus Pharmaceuticals, ... (PVCT) | 20-Mar-14 | Option Exercise | 639,248 | $0.93 | $592,436.00 | 12% 5.4M to 6.04M | |
| 28-Feb-14 10:11 AM View: | Culpepper Peter R CFO & COO | Provectus Pharmaceuticals, ... (PVCT) | 26-Feb-14 | Option Exercise | 121,000 | $1.10 | $133,100.00 | 12% 1.01M to 1.13M | |
| 28-Feb-14 10:11 AM View: | Culpepper Peter R CFO & COO | Provectus Pharmaceuticals, ... (PVCT) | 26-Feb-14 | Option Exercise | 68,624 | $1.10 | $75,486.40 | 7% 943.71K to 1.01M | |
| 28-Feb-14 10:09 AM View: | Scott Timothy Phd President | Provectus Pharmaceuticals, ... (PVCT) | 26-Feb-14 | Option Exercise | 300,000 | $1.10 | $330,000.00 | 21% 1.46M to 1.76M | |
| 24-Sep-13 6:24 PM View: | Koe Jan Director | Provectus Pharmaceuticals, ... (PVCT) | 20-Sep-13 | Purchase | 100,000 | -- | -- | 16% 636.3K to 736.3K | |
| 30-May-13 10:50 AM View: | Dees H Craig Chief Executive Officer Director | Provectus Pharmaceuticals, ... (PVCT) | 29-May-13 | Option Exercise | 43,750 | $0.48 | $21,000.00 | 3% 1.45M to 1.5M | |
| 03-Dec-12 12:41 PM View: | Culpepper Peter R CFO, COO | Provectus Pharmaceuticals, ... (PVCT) | 03-Dec-12 | Purchase | 133,333 | -- | -- | 16% 810.38K to 943.71K | |
| 20-Nov-12 4:25 PM View: | Culpepper Peter R CFO, COO | Provectus Pharmaceuticals, ... (PVCT) | 16-Nov-12 | Purchase | 133,333 | -- | -- | 20% 677.04K to 810.38K | |
| 20-Nov-12 4:26 PM View: | Wachter Eric Phd Chief Technology Officer | Provectus Pharmaceuticals, ... (PVCT) | 16-Nov-12 | Purchase | 666,666 | -- | -- | 14% 4.73M to 5.4M | |
| 07-Dec-11 12:17 PM View: | Wachter Eric Phd Vice President Pharmaceuticals Director | Provectus Pharmaceuticals, ... (PVCT) | 05-Dec-11 | Option Exercise | 100,000 | $0.75 | $75,000.00 | 2% 4.63M to 4.73M | (87%) |
| 02-Dec-11 3:51 PM View: | Wachter Eric Phd Vice President Pharmaceuticals Director | Provectus Pharmaceuticals, ... (PVCT) | 01-Dec-11 | Option Exercise | 100,000 | $0.93 | $93,000.00 | 2% 4.53M to 4.63M | |
| 28-Nov-11 1:40 PM View: | Wachter Eric Phd Vice President Pharmaceuticals Director | Provectus Pharmaceuticals, ... (PVCT) | 23-Nov-11 | Option Exercise | 100,000 | $0.93 | $93,000.00 | 2% 4.43M to 4.53M | |
| 20-Oct-11 2:09 PM View: | Wachter Eric Phd Vice President Pharmaceuticals Director | Provectus Pharmaceuticals, ... (PVCT) | 19-Oct-11 | Option Exercise | 100,000 | $0.93 | $93,000.00 | 2% 4.33M to 4.43M | (90%) |
| 06-Oct-11 4:31 PM View: | Scott Timothy Phd President Director | Provectus Pharmaceuticals, ... (PVCT) | 06-Oct-11 | Option Exercise | 100,000 | $0.39 | $39,000.00 | 7% 1.36M to 1.46M | |
| 08-Sep-11 1:54 PM View: | Wachter Eric Phd Vice President Pharmaceuticals Director | Provectus Pharmaceuticals, ... (PVCT) | 07-Sep-11 | Option Exercise | 100,000 | $0.93 | $93,000.00 | 2% 4.23M to 4.33M | (90%) |
| 01-Aug-11 3:30 PM View: | Wachter Eric Phd Vice President Pharmaceuticals Director | Provectus Pharmaceuticals, ... (PVCT) | 29-Jul-11 | Option Exercise | 100,000 | $1.00 | $100,000.00 | 2% 4.13M to 4.23M | (91%) |
| 04-May-11 3:07 PM View: | Culpepper Peter R Chief Financial Officer | Provectus Pharmaceuticals, ... (PVCT) | 03-May-11 | Option Exercise | 133,333 | $0.75 | $99,999.80 | 25% 543.71K to 677.04K | |
| 04-May-11 3:13 PM View: | Wachter Eric Phd Vice President Pharmaceuticals Director | Provectus Pharmaceuticals, ... (PVCT) | 03-May-11 | Option Exercise | 100,000 | $1.00 | $100,000.00 | 2% 4.03M to 4.13M | (91%) |
| 21-Apr-11 10:00 PM View: | Wachter Eric Phd Vice President Pharmaceuticals Director | Provectus Pharmaceuticals, ... (PVCT) | 20-Apr-11 | Option Exercise | 100,000 | $1.00 | $100,000.00 | 3% 3.93M to 4.03M | (91%) |
| 13-Apr-11 12:22 PM View: | Wachter Eric Phd Vice President Pharmaceuticals Director | Provectus Pharmaceuticals, ... (PVCT) | 12-Apr-11 | Option Exercise | 150,000 | $1.00 | $150,000.00 | 4% 3.78M to 3.93M | (91%) |
| 08-Feb-11 1:43 PM View: | Wachter Eric Phd Vice President Pharmaceuticals Director | Provectus Pharmaceuticals, ... (PVCT) | 07-Feb-11 | Option Exercise | 8,333 | $0.75 | $6,249.75 | < 1% 3.77M to 3.78M | |
| 04-Feb-11 1:56 PM View: | Wachter Eric Phd Vice President Pharmaceuticals Director | Provectus Pharmaceuticals, ... (PVCT) | 03-Feb-11 | Option Exercise | 125,000 | $0.75 | $93,750.00 | 3% 3.65M to 3.77M | |
| 30-Dec-10 12:01 PM View: | Wachter Eric Phd Vice President Pharmaceuticals Director | Provectus Pharmaceuticals, ... (PVCT) | 29-Dec-10 | Option Exercise | 400,000 | $1.00 | $400,000.00 | 12% 3.25M to 3.65M | (91%) |
| 30-Dec-10 11:50 AM View: | Culpepper Peter R Chief Financial Officer | Provectus Pharmaceuticals, ... (PVCT) | 29-Dec-10 | Option Exercise | 133,333 | $0.75 | $99,999.80 | 32% 410.38K to 543.71K | |
| 22-Nov-10 12:28 PM View: | Wachter Eric Phd Vice President Pharmaceuticals Director | Provectus Pharmaceuticals, ... (PVCT) | 19-Nov-10 | Option Exercise | 100,000 | $1.00 | $100,000.00 | 3% 3.15M to 3.25M | (91%) |
| 07-Sep-10 2:36 PM View: | Wachter Eric Phd Vice President Pharmaceuticals Director | Provectus Pharmaceuticals, ... (PVCT) | 07-Sep-10 | Option Exercise | 100,000 | $1.00 | $100,000.00 | 3% 3.05M to 3.15M | (90%) |
| 12-Jul-10 12:03 PM View: | Wachter Eric Phd Vice President Pharmaceuticals Director | Provectus Pharmaceuticals, ... (PVCT) | 09-Jul-10 | Option Exercise | 75,000 | $1.10 | $82,500.00 | 3% 2.97M to 3.05M | (91%) |
| 29-Apr-10 11:21 AM View: | Wachter Eric Phd Vice President Pharmaceuticals Director | Provectus Pharmaceuticals, ... (PVCT) | 28-Apr-10 | Option Exercise | 157,888 | $0.68 | $106,814.00 | 6% 2.82M to 2.97M |
